Legionellosis-Associated Hospitalization in Spain from 2002 to 2021.

Enrique Gea-Izquierdo, Ruth Gil-Prieto, Valentín Hernández-Barrera, Gil Rodríguez-Caravaca, Ángel Gil-de-Miguel
Author Information
  1. Enrique Gea-Izquierdo: Preventive Medicine and Public Health, Rey Juan Carlos University, 28922 Madrid, Spain. ORCID
  2. Ruth Gil-Prieto: Preventive Medicine and Public Health, Rey Juan Carlos University, 28922 Madrid, Spain. ORCID
  3. Valentín Hernández-Barrera: Preventive Medicine and Public Health, Rey Juan Carlos University, 28922 Madrid, Spain.
  4. Gil Rodríguez-Caravaca: Preventive Medicine and Public Health, Rey Juan Carlos University, 28922 Madrid, Spain. ORCID
  5. Ángel Gil-de-Miguel: Preventive Medicine and Public Health, Rey Juan Carlos University, 28922 Madrid, Spain. ORCID

Abstract

Legionellosis is a respiratory disease of bacterial and environmental origin that usually presents two distinct clinical entities, "Legionnaires' disease" (LD) and "Pontiac fever". LD is an important cause of hospital-acquired pneumonia (HAP). The objective of this study is to describe the epidemiology of legionellosis-associated hospitalization (L-AH) in Spain from 2002 to 2021 and the burden of hospitalization due to legionellosis. Discharge reports from the Minimum Basic Data Set (MBDS) were used to retrospectively analyze hospital discharge data with a diagnosis of legionellosis, based on the ICD-9-CM and ICD-10-CM diagnosis codes, from 2002 to 2021. 21,300 L-AH occurred throughout the year during 2002-2021. The incidence of hospitalization associated per 100,000 inhabitants by month showed a similar trend for the 2002-2011, 2012-2021, and 2002-2021 periods. In Spain, during 2002-2021, the hospitalization rate (HR) in the autonomous communities ranged from 4.57 (2002-2011) to 0.24 (2012-2021) cases per 100,000 inhabitants. The HR of legionellosis in Spain has substantially increased across the 2002-2021 period, and the estimate is consistent with available European data. It is considered that in-depth epidemiological surveillance studies of legionellosis and improvements in the prevention and control of the disease are required in Spain.

Keywords

References

  1. Microorganisms. 2022 Feb 23;10(3): [PMID: 35336074]
  2. Lancet Infect Dis. 2014 Oct;14(10):1011-21 [PMID: 24970283]
  3. PLoS One. 2021 Apr 22;16(4):e0250364 [PMID: 33886659]
  4. Lancet. 2016 Jan 23;387(10016):376-385 [PMID: 26231463]
  5. Diagnostics (Basel). 2021 Jul 02;11(7): [PMID: 34359283]
  6. Curr Issues Mol Biol. 2021;42:81-96 [PMID: 33284133]
  7. Sci Rep. 2020 Apr 30;10(1):7337 [PMID: 32355282]
  8. Microorganisms. 2022 Apr 01;10(4): [PMID: 35456814]
  9. J Microbiol Immunol Infect. 2022 Dec;55(6 Pt 2):1159-1167 [PMID: 35570184]
  10. Emerg Infect Dis. 2020 Oct;26(10):2309-2318 [PMID: 32946366]
  11. Emerg Infect Dis. 2021 Jan;27(1):255-257 [PMID: 33350911]
  12. Euro Surveill. 2022 May;27(21): [PMID: 35621000]
  13. Stat Med. 2000 Feb 15;19(3):335-51 [PMID: 10649300]
  14. Infect Dis Health. 2023 Feb;28(1):27-38 [PMID: 36038465]
  15. BMC Infect Dis. 2010 May 21;10:124 [PMID: 20492639]
  16. Euro Surveill. 2017 Jul 6;22(27): [PMID: 28703097]
  17. Acta Clin Belg. 2022 Aug;77(4):753-759 [PMID: 34520336]
  18. Microorganisms. 2021 Oct 20;9(11): [PMID: 34835307]
  19. Commun Dis Intell (2018). 2022 Jun 23;46: [PMID: 35739069]
  20. Hum Vaccin Immunother. 2022 Dec 31;18(1):1883379 [PMID: 33653212]
  21. Epidemiol Infect. 2018 Oct;146(14):1824-1833 [PMID: 30099976]
  22. Emerg Infect Dis. 2022 Mar;28(3):527-538 [PMID: 35195513]
  23. Microorganisms. 2020 Dec 18;8(12): [PMID: 33352932]
  24. Lancet Microbe. 2022 Nov;3(11):e835-e845 [PMID: 36240833]
  25. BMC Infect Dis. 2022 Jun 15;22(1):550 [PMID: 35705915]
  26. Euro Surveill. 2021 Jun;26(25): [PMID: 34169817]
  27. Pneumonia (Nathan). 2021 Jan 6;13(1):2 [PMID: 33407911]
  28. Euro Surveill. 2023 Mar;28(11): [PMID: 36927719]
  29. Environ Sci Pollut Res Int. 2022 Nov;29(51):76532-76542 [PMID: 36161570]

Word Cloud

Created with Highcharts 10.0.0Spainhospitalizationlegionellosis2002-2021disease20022021LDL-AHdatadiagnosisper100000inhabitants2002-20112012-2021HRLegionellosisrespiratorybacterialenvironmentaloriginusuallypresentstwodistinctclinicalentities"Legionnaires'disease""Pontiacfever"importantcausehospital-acquiredpneumoniaHAPobjectivestudydescribeepidemiologylegionellosis-associatedburdendueDischargereportsMinimumBasicDataSetMBDSusedretrospectivelyanalyzehospitaldischargebasedICD-9-CMICD-10-CMcodes21300occurredthroughoutyearincidenceassociatedmonthshowedsimilartrendperiodsrateautonomouscommunitiesranged457024casessubstantiallyincreasedacrossperiodestimateconsistentavailableEuropeanconsideredin-depthepidemiologicalsurveillancestudiesimprovementspreventioncontrolrequiredLegionellosis-AssociatedHospitalizationCOVID-19Legionnaires’

Similar Articles

Cited By